17 completed. 17 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 17 | Completed 17 |
Follow Nephrosis: new trials by email Literature Review of Nephrosis trials Research Report on Nephrosis
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Atorvastatin Therapy in the Treatment of Dyslipidemia in Children With Steroid Sensitive Nephrotic Syndrome Atorvastatin - Dyslipidaemia | Phase 4 | Completed | National Institute of Kidney Disease and Urology (NIKDU) | 100 | 2024-01-27 | 2026-03-27 |
| Clinical Value of Adding Dapagliflozin in Patients With Nephrotic Syndrome Dapagliflozin 10mg Tab - Nephrotic Syndrome, Sodium-Glucose Transporter 2 Inhibitors | Phase 4 | Completed | Ain Shams University | 60 | 2022-08-01 | 2023-09-07 |
| Study of Tacrolimus vs Mycophenolate Mofetil in Pediatric Patients With Nephrotic Syndrome Tacrolimus, Mycophenolate Mofetil - Nephrotic Syndrome in Children | Phase 4 | Completed | The Children's Hospital of Zhejiang University School of Medicine | 270 | 2019-11-12 | 2023-10-17 |
| Active Vitamin D And Reduced Dose Prednisolone for Treatment in Minimal Change Nephropathy Prednisolone, Alfacalcidol - Minimal Change Disease, Nephrotic Syndrome | Phase 4 | Completed | University of Aarhus | 71 | 2018-05-01 | 2025-01-24 |
| Role of Acetazolamide and Hydrochlorothiazide Followed by Furosemide in Treating Nephrotic Edema Acetazolamide and Hydrochlorothiazide Followed by Furosemide, Furosemide and Hydrochlorothiazide Followed by Furosemide - Nephrotic Syndrome, Edema | Phase 4 | Completed | Shiraz University of Medical Sciences | 20 | 2015-04-01 | 2016-02-23 |
| Efficacy of Usual Vitamin D Supplementation and Its Impact on Children and Adolescents Calciuria. Cholecalciferol vial (100 000 UI) - Chronic Kidney Disease, Renal Transplantation | Phase 4 | Completed | Hospices Civils de Lyon | 43 | 2014-09-01 | 2025-09-04 |
| Mycophenolate Mofetil in Pediatric Steroid Dependent Nephrotic Syndrome Mycophenolate mofetil - Nephrotic Syndrome | Phase 4 | Completed | Seoul National University Hospital | 34 | 2013-09-01 | 2017-07-06 |
| A Study to Evaluate the Effect of Tacrolimus and Corticosteroid Combination Therapy in Patients With Minimal Change Nephrotic Syndrome Tacrolimus, Prednisolone - MCNS, Minimal Change Nephrotic Syndrome (MCNS) | Phase 4 | Completed | Astellas Pharma Korea, Inc. | 144 | 2012-07-16 | 2024-10-31 |
| Pharmacokinetics of Tacrolimus in Children Tacrolimus - Nephrotic Syndrome | Phase 4 | Completed | Shandong University | 28 | 2012-01-01 | 2017-11-20 |
| Acthar for Treatment of Proteinuria in Membranous Nephropathy Patients Repository Corticotropin Injection, Placebo - Proteinuria, Idiopathic Membranous Nephropathy | Phase 4 | Completed | Mallinckrodt | 60 | 2011-08-01 | 2019-11-20 |
| Myfortic® for Minimal Change Nephrotic Syndrome (MCNS): a Randomized Study Myfortic plus low-dose steroid, Prednisolone - Nephrosis, Lipoid | Phase 4 | Completed | The University of Hong Kong | 20 | 2010-09-01 | 2018-06-01 |
| Therapeutic Effect of Tacrolimus on Primary Nephrotic Syndrome in Children Tacrolimus - Nephrotic Syndrome | Phase 4 | Completed | Seoul National University Hospital | 77 | 2010-07-01 | 2019-02-07 |
| Tacrolimus Versus Prednisolone for the Treatment of Minimal Change Disease tacrolimus, prednisolone - Minimal Change Disease | Phase 4 | Completed | Imperial College Healthcare NHS Trust | 52 | 2009-12-01 | 2021-05-04 |
| Prospective Study Evaluating the Effect of Repository Corticotropin in the Treatment of Various Nephrotic Syndromes Repository corticotrophin - Nephrotic Syndromes | Phase 4 | Completed | Arizona Kidney Disease and Hypertension Center | 18 | 2009-12-01 | 2011-07-14 |
| Treatment of Resistant Nephrotic Syndrome With ACTH Gel (ACTHAR) ACTHAR gel - Treatment Resistant Nephrotic Syndrome | Phase 4 | Completed | Columbia University | 15 | 2009-12-01 | 2014-04-24 |
| Adrenocorticotropic Hormone (ACTH) Treatment of Nephrotic Range Proteinuria in Diabetic Nephropathy (NRDN) ACTH - Diabetic Nephropathy, Nephrotic Syndrome | Phase 4 | Completed | Southeast Renal Research Institute | 15 | 2009-05-01 | 2013-05-31 |
| HSP-glomerulonephritis Trial: MP vs CyA Methylprednisolone pulses plus prednisone versus Cyclosporine A - Purpura, Schoenlein-Henoch | Phase 4 | Completed | Oulu University Hospital | 20 | 2000-01-01 | 2011-08-08 |
Nephrotic Syndrome (15) · Nephrosis, Lipoid (5) · Proteinuria (3) · Glomerulonephritis (2) · Glomerulonephritis, Membranous (2) · Nephritis (2) · Diabetic Nephropathies (1) · Dyslipidemias (1) · Edema (1) · Glomerulonephritis, IGA (1) · Glomerulosclerosis, Focal Segmental (1) · IgA Vasculitis (1) · Kidney Diseases (1) · Renal Insufficiency, Chronic (1)
Female Urogenital Diseases (17) · Female Urogenital Diseases and Pregnancy Complications (17) · Male Urogenital Diseases (17) · Urogenital Diseases (17) · Urologic Diseases (17) · Kidney Diseases (16) · Pathological Conditions, Signs and Symptoms (5) · Signs and Symptoms (4) · Immune System Diseases (3) · Nephritis (3) · Urination Disorders (3) · Urological Manifestations (3) · Autoimmune Diseases (2) · Glomerulonephritis (2)
Tacrolimus (5) · Prednisolone (4) · Mycophenolic Acid (3) · Adrenocorticotropic Hormone (2) · Acetazolamide (1) · Atorvastatin (1) · Furosemide (1) · Prednisone (1) · Steroids (1) · Tablets (1) · alfacalcidol (1) · dapagliflozin (1)
Seoul National University Hospital (2) · Ain Shams University (1) · Arizona Kidney Disease and Hypertension Center (1) · Astellas Pharma Korea, Inc. (1) · Columbia University (1) · Hospices Civils de Lyon (1) · Imperial College Healthcare NHS Trust (1) · Mallinckrodt (1) · National Institute of Kidney Disease and Urology (NIKDU) (1) · Oulu University Hospital (1) · Shandong University (1) · Shiraz University of Medical Sciences (1) · Southeast Renal Research Institute (1) · The Children's Hospital of Zhejiang University School of Medicine (1) · The University of Hong Kong (1)
United States (4) · South Korea (3) · China (2) · Bangladesh (1) · Canada (1) · Chile (1) · Denmark (1) · Egypt (1) · Finland (1) · France (1) · Mexico (1) · Turkey (Türkiye) (1) · United Kingdom (1)
Gerald B Appel, MD (1) · Hee Gyung Aurea Kang, M.D., Ph.D. (1) · James A. Tumlin, MD (1) · Jianhua Mao, MD (1) · Justine Bacchetta, MD (1) · Matti Nuutinen, M.D., Ph.D. (1) · Megan Griffith, MBChBPhDFRCP (1) · Mohammad Mahdi Sagheb, MD (1) · Per Ivarsen (1) · Saieef Zaman, MD (1) · Sungchun Lee, M.D. (1) · Sydney CW Tang, MD, PhD (1)
PMID 35230699, PMID 39513526, PMID 12944064, PMID 14655180, PMID 16961774, PMID 17489822, PMID 17989649, PMID 21626222, PMID 22722778, PMID 23343906, PMID 23813218, PMID 24009220, PMID 24159603, PMID 31769845, PMID 31873802, PMID 34247632, PMID 34778952, PMID 3588043, PMID 36853224, PMID 40354041, PMID 41905593, PMID 7479966, PMID 7911091, PMID 9176846, PMID 9469489
2009 (1)